Response to baricitinib therapy in patients with rheumatoid arthritis with inadequate response to csDMARDs as a function of baseline characteristics RMD OPEN Kremer, J. M., Schiff, M., Muram, D., Zhong, J., Alam, J., Genovese, M. C. 2018; 4 (1)

View details for DOI 10.1136/rmdopen-2017-000581

View details for Web of Science ID 000427250300009